Your gut lining, and what "leaky gut" actually means
One cell thick, the surface of a small flat, and held shut by a protein gate that has a named off switch. Here is what the barrier really is, what genuinely opens it, and where the internet went past the evidence.
"Leaky gut" is a real measurable phenomenon with a real literature and a real unresolved argument at the centre of it. This article prints the argument rather than picking the convenient side.
The short answer
Your gut lining is one cell thick, and the cells are stitched together by protein seals called tight junctions. Those seals open and close on purpose. Increased intestinal permeability is measurable and is documented in coeliac disease, type 1 diabetes and other conditions. What is still argued over is direction: whether the opening causes the disease, or the disease causes the opening.
In this article
What the lining physically is
Start with the object itself, because most confusion about the gut lining is confusion about scale. Between the contents of your intestine and your bloodstream there is a single layer of cells. One. Everything you have ever eaten has been separated from your blood by a sheet the thickness of one cell.
That sheet has a job with two halves that pull against each other. It has to let nutrients through, which means it cannot be sealed. It has to keep microbes and undigested food proteins out, which means it cannot be open. A review in International Review of Cell and Molecular Biology puts the design problem plainly: the epithelial layer orchestrates a dynamic balance between nutrient absorption and prevention of microorganism and antigen intrusion.1
The way it manages both at once is that the gate is not in the cells. It is between them.
Tight junctions, the part that actually opens
Where two neighbouring cells meet, a ring of proteins clamps the two membranes together and seals the gap. These are tight junctions, and they are not passive glue. They are multiprotein adhesion complexes that regulate paracellular permeability, meaning the traffic of ions and solutes through the space between cells rather than through the cells themselves.1
The same review notes they do more than seal. Tight junctions carry signalling that controls cell polarisation, proliferation, migration, differentiation and survival.1 The seal is also a switchboard. That is why damage to it is not simply a hole. It is a change in how the lining behaves.
Figure 01
The barrier, in three plain facts
Zonulin is described in the literature as the only known physiological regulator of tight junction permeability. That is a strong claim, and it is the reason so much of this field runs through one molecule.
Source: Jauregi-Miguel A. Int Rev Cell Mol Biol, 2020;358:105 to 132, retrieved via PubMed.
Zonulin: the off switch with a name
Here is the part that makes the whole subject concrete rather than mystical. The tight junction has a documented physiological release mechanism, and it has a name. Zonulin. The review above calls it the only known physiological regulator of tight junction permeability, and reports that it appears elevated in autoimmune conditions associated with tight junction dysfunction, including coeliac disease.1
Zonulin is not a hypothetical. The pathway has been traced end to end in one specific case. Gluten peptides bind the chemokine receptor CXCR3 and induce release of zonulin, which mediates tight junction disassembly and a subsequent increase in intestinal permeability.2 That is a food component, a receptor, a signal molecule, and a measurable change in the barrier, in sequence.
The gut does not spring a leak. It opens a gate, on a signal, using a molecule that has a name.
The strongest case: coeliac disease
Coeliac disease is where the barrier story is best documented, and it is the model everything else in this field is compared against. It is a systemic immune mediated disorder triggered by gluten in genetically susceptible people, and it is associated with altered gut permeability.3
Two details from that literature matter for anyone reading about their own gut. First, in coeliac disease the molecular structure and function of tight junctions appear disrupted, and they are not completely recovered even after treatment with a gluten free diet.1 Removing the trigger does not automatically restore the seal, at least not fully, and not fast.
Second, the barrier has been treated as a drug target. Larazotide acetate is a synthetic peptide developed specifically as a permeability regulator, designed to inhibit the actin rearrangement caused by gliadin, and it has been taken into clinical studies.4 Whatever you think of the internet version of leaky gut, pharmaceutical programmes were built on the underlying mechanism.
The honest caveat, printed in full
Now the part that most articles on this subject leave out. A 2019 review by Valitutti and Fasano, published in Digestive Diseases and Sciences, opens by saying that for decades the pathogenesis of a variety of human diseases has been attributed to increased intestinal paracellular permeability even though the scientific evidence supporting this hypothesis has been tenuous.3
That is not a sceptic writing. Fasano is the researcher most closely associated with zonulin and with the barrier hypothesis itself. He is saying, in his own review, that the general claim outran the evidence for a long time. What he then argues is narrower and better supported: that over the past decade, work in human genetics, the microbiome and proteomics suggests loss of mucosal barrier function may substantially affect antigen trafficking and ultimately cause chronic inflammation, including autoimmunity, in genetically predisposed individuals.3
Read the qualifier. In genetically predisposed individuals. The barrier is one of several conditions that have to be met, not a universal explanation for feeling unwell.
Figure 02
What is established, and what is not
The same evidence base, sorted by how firm each claim actually is.
Swipe to see the whole table
| Claim | Status | Where it comes from |
|---|---|---|
| Permeability can be measured and can increase | Established | Coeliac and diabetes literature |
| Zonulin opens tight junctions | Established mechanism | Gliadin to CXCR3 to zonulin pathway |
| Gluten raises permeability in coeliac disease | Established | Pre-clinical and clinical studies |
| Barrier loss contributes to autoimmunity in predisposed people | Supported, still debated | Valitutti and Fasano review, 2019 |
| Barrier changes are involved in type 1 and type 2 diabetes | Proposed mechanism | Obesity Reviews, 2011 |
| "Leaky gut" explains general fatigue, brain fog or bloating | Not established | No trial support cited here |
| A supplement can seal the gut lining | Not established | The one designed drug is still investigational |
Sources: Valitutti F, Fasano A. Dig Dis Sci, 2019, Jauregi-Miguel A. Int Rev Cell Mol Biol, 2020, de Kort S, Keszthelyi D, Masclee AAM. Obes Rev, 2011. Retrieved via PubMed.
Beyond coeliac: where else the barrier turns up
A review in Obesity Reviews examined the barrier in both types of diabetes. Its proposed sequence is worth reading slowly, because it is the general shape of every barrier hypothesis: altered permeability compromises barrier function, which facilitates access of infectious agents and dietary antigens to mucosal immune elements, which may eventually lead to immune reactions damaging pancreatic beta cells, and to increased cytokine production with consequent insulin resistance.5
Note the verbs. Facilitates. May eventually lead. This is a mechanism under investigation, and the review says as much: understanding the factors regulating barrier function will provide important insight, and reinforcing the barrier may open new therapeutic horizons.5 May open. Not has opened.
The connection between the barrier and immune self attack is the subject of its own article. If that is what brought you here, read the gut and autoimmune issues, which covers the translocation experiments directly.
What the barrier is actually made of, and what feeds it
The lining is not only cells and seals. Sitting on top is a mucus layer, and the whole system is fed by a fuel your own cells largely do not make. Short chain fatty acids, produced when gut bacteria ferment material you could not digest, are the main energy source for the cells of the colon lining.
A 2024 study in Nutrients gives an unusually clean picture of what that fuel does. Butyrate given to weaned mice enhanced the mucin layer and the morphological structure of the intestine, improved the integrity of the intestinal brush border, and accelerated tight junction development.6 The same work found it shifted immune cell populations in the gut and moved the microbial community toward an adult structure.6
Two honest qualifications. That was mice, at a developmental stage, and it does not transfer directly to an adult human. And butyrate in a human colon comes overwhelmingly from bacterial fermentation of dietary fibre rather than from swallowing butyrate. The practical version of this finding is not a supplement. It is feeding the population that makes it.
What would actually count as evidence
If you want to hold this subject to a standard, hold it to the one the field holds itself to. Coeliac disease got its status because there is a named trigger, a genetic requirement, a traced signalling pathway, a measurable barrier change, and a drug built on the mechanism and put into clinical trials.34 That is five kinds of evidence agreeing.
Most popular claims about leaky gut have none of the five. That does not make the barrier unimportant. It makes it a real and active research area that has been borrowed by people selling things, which is a different problem entirely, and one you can spot from the outside once you know what the careful version sounds like.
Frequently asked questions
Is leaky gut real?
Increased intestinal permeability is real, measurable and documented in coeliac disease among other conditions. "Leaky gut syndrome" as a standalone diagnosis explaining general symptoms is not an established medical entity. Those are two different claims and they get treated as one.
What is zonulin?
Zonulin is described in the literature as the only known physiological regulator of tight junction permeability. Gluten peptides bind the chemokine receptor CXCR3 and induce its release, which mediates tight junction disassembly and a subsequent increase in intestinal permeability. It appears elevated in several autoimmune conditions associated with tight junction dysfunction.
Does a gluten free diet repair the gut lining?
In coeliac disease it is the treatment, but the review evidence states that the molecular structure and function of tight junctions are not completely recovered even after treatment with a gluten free diet. Removing the trigger is necessary and is not, on the evidence, automatically sufficient for full barrier restoration.
Can a supplement seal my gut?
No supplement has been shown to do that. The one agent designed specifically as a tight junction permeability regulator, larazotide acetate, is a synthetic peptide developed as a pharmaceutical and studied in clinical trials for coeliac disease. Food is not a substitute for that, and neither is anything sold as a gut repair powder.
Is butyrate worth taking?
The barrier effects documented for butyrate, including an enhanced mucin layer and accelerated tight junction development, come from animal work at a developmental stage. In humans, butyrate in the colon is produced mainly by bacterial fermentation of dietary fibre. Feeding that fermentation has a clearer rationale than swallowing the end product.
Sources
- Jauregi-Miguel A. The tight junction and the epithelial barrier in coeliac disease. International Review of Cell and Molecular Biology, 2020;358:105 to 132. doi.org/10.1016/bs.ircmb.2020.09.010
- Rallabhandi P. Gluten and celiac disease, an immunological perspective. Journal of AOAC International, 2012;95(2):349 to 355. doi.org/10.5740/jaoacint.sge_rallabhandi
- Valitutti F, Fasano A. Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments. Digestive Diseases and Sciences, 2019;64(7):1748 to 1758. doi.org/10.1007/s10620-019-05646-y
- Khaleghi S, Ju JM, Lamba A, Murray JA. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therapeutic Advances in Gastroenterology, 2016;9(1):37 to 49. doi.org/10.1177/1756283X15616576
- de Kort S, Keszthelyi D, Masclee AAM. Leaky gut and diabetes mellitus: what is the link? Obesity Reviews, 2011;12(6):449 to 458. doi.org/10.1111/j.1467-789X.2010.00845.x
- Wang H, Qiu J, Zhou M, Luo Y, Li X, Wang M. Monobutyrin Can Regulate the Gut Microbiota, Which Is Beneficial for the Development of Intestinal Barrier Function and Intestinal Health in Weaned Mice. Nutrients, 2024;16(13):2052. doi.org/10.3390/nu16132052
All references retrieved via PubMed.
